1.7900
-0.0200
(-1.10%)
At close: January 24 at 4:00:01 PM EST
1.8000
+0.01
+(0.56%)
After hours: January 24 at 4:45:15 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 3 | 7 | 9 |
| Avg. Estimate | -0.55 | -0.45 | -1.77 | -1.15 |
| Low Estimate | -0.72 | -0.51 | -1.95 | -2.44 |
| High Estimate | -0.07 | -0.42 | -1.28 | 0.09 |
| Year Ago EPS | -0.49 | -0.38 | -1.56 | -1.77 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 1 | 9 | 9 |
| Avg. Estimate | 21.31M | -- | 65.66M | 42.37M |
| Low Estimate | 15M | -- | 61.2M | -- |
| High Estimate | 43.9M | -- | 90.2M | 114.7M |
| Year Ago Sales | 15.19M | 15.89M | 97.06M | 65.66M |
| Sales Growth (year/est) | 40.26% | -100.00% | -32.36% | -35.46% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.76 | -0.49 | -0.48 | -0.53 |
| EPS Actual | -0.49 | -0.38 | -0.4 | -0.43 |
| Difference | 0.27 | 0.11 | 0.08 | 0.1 |
| Surprise % | 35.29% | 22.45% | 17.24% | 18.85% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.55 | -0.45 | -1.77 | -1.71 |
| 7 Days Ago | -0.54 | 0.12 | -1.76 | -1.15 |
| 30 Days Ago | -0.57 | 0.12 | -1.8 | -1.15 |
| 60 Days Ago | -0.61 | 0.74 | -1.82 | -1.15 |
| 90 Days Ago | -0.58 | 0.4 | -1.89 | -1.32 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 3 | 1 | 3 | 1 |
| Down Last 7 Days | 1 | -- | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALEC | -11.57% | -19.30% | -13.78% | 35.08% |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Downgrade | Stifel: Buy to Hold | 12/16/2024 |
| Downgrade | Morgan Stanley: Equal-Weight to Underweight | 11/26/2024 |
| Maintains | BTIG: Buy to Buy | 11/26/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 11/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/7/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 9/17/2024 |
Related Tickers
GOSS Gossamer Bio, Inc.
0.9300
+4.98%
PASG Passage Bio, Inc.
0.6060
-1.85%
DNLI Denali Therapeutics Inc.
22.22
-4.55%
AKRO Akero Therapeutics, Inc.
26.18
+0.08%
STOK Stoke Therapeutics, Inc.
10.62
+0.19%
LYEL Lyell Immunopharma, Inc.
0.6050
+3.56%
NKTX Nkarta, Inc.
2.4900
-1.58%
ACET Adicet Bio, Inc.
0.9218
-2.29%
CTMX CytomX Therapeutics, Inc.
0.8911
+2.68%
DTIL Precision BioSciences, Inc.
5.08
+1.60%